In this article, we present a comprehensive overview of the regulatory landscape governing Chinese medicinal practices in Australia, in which we describe the regulations for Chinese medicine practitioners in Australia, as of 2024, focusing in particular on the Title Protection model under the Health Practitioner Regulation National Law. Central to this discussion are the core roles of the Chinese Medicine Board of Australia (the Board) and the Australian Health Practitioner Regulation Agency (Ahpra) in ensuring public safety by guaranteeing that practitioners are appropriately qualified and suitable for registration. We also examine the structure and demographics of the Chinese medicine workforce in Australia and present details of the required registration process for practitioners. In addition, the article outlines specific requirements for registration, including the standards set by the Board for initial and ongoing registration, which are administered with the support of Ahpra under the National Registration and Accreditation Scheme. Furthermore, we present details regarding the approved qualifications, the rigorous assessment process for overseas qualifications, and the important role of regulatory examinations designed to uphold the high standards expected of practitioners, thereby ensuring they have acquired the professional competencies required by the Australian healthcare system. This overview offers valuable insights for both current and prospective practitioners of Chinese medicine in Australia.

Chinese medicine, with its rich historical roots and holistic approach, has been a fundamental aspect of healthcare in East Asia and is now gaining global recognition. Founded on centuries of empirical knowledge and philosophical insight, Chinese medicine draws heavily from classical texts to guide its practices in herbal medicine and acupuncture. Despite its cultural and historical significance, integrating Chinese medicine into global healthcare systems presents challenges, notably the need for evidence-based practices to enhance credibility, ensure patient safety, and foster broader acceptance within the medical community. This paper explores how Chinese medicine can adopt evidence-based practices by incorporating principles of Western medicine into its research methodologies. It reviews the origins and philosophical foundations of Chinese medicine, examining its reliance on classical texts and empirical methods. The paper also highlights the differences between the personalised approach of Chinese medicine, which tailors treatments to individual needs, and the standardised protocols typical of Western medicine. Additionally, it addresses methodological challenges in Chinese medicine research, such as inconsistent diagnostic criteria and insufficient design rigour. To bridge these gaps, innovative research methodologies that respect the unique variability of Chinese medicine are needed. By adopting evidence-based practices and rigorous scientific validation, Chinese medicine can enhance its legitimacy and facilitate its integration into the global healthcare landscape.

In recent years, the gut microbiota has become an integral research topic in human health owing to its impact on digestion, immunity, metabolic processes, and mental health. The possibilities of microbiome treatment have increased interest in dietary approaches, with a special focus on the intake of fermented foods. This has revived some of the most profound and practical constructs derived from food therapy in Chinese medicine (CM), where food therapy, along with fermented options, actively preserves health and prevents disease. In CM, the spleen and stomach system refers to the postnatal foundation of the body, which controls the processes of chewing, nutrient assimilation, and energy production (qi). The balance between intestinal and overall health is the foundation of psychosomatic well-being and is of utmost importance. Fermented foods can boost the spleen, alleviate stagnant food syndrome, dispel excess fluids, enhance protective functions, and strengthen the immune system. This review aimed to integrate the conceptual and clinical paradigms of CM with those of Western medicine, focusing on the role of fermented foods in gut microbiota regulation. This article discusses prominent fermented foods in CM and their classical functions, alongside the currently available peer-reviewed literature (published within the last 7 years) on their impact on gut flora and other clinical outcomes. Mechanistic considerations regarding the production of probiotics and other active metabolites, such as short-chain fatty acids, and the modulation of the intestinal barrier are discussed. This review also examines multidisciplinary approaches to dietary customs worldwide and outlines the clinical applications of these findings in the context of chronic disease management and gastrointestinal health.